Nevro Acquires Vyrsa Technologies; Paid $40M At Closing, To Pay Up To An Additional $35M In Cash Or Stock Tied To Achievement Of Certain Milestones
Portfolio Pulse from Benzinga Newsdesk
Nevro Corp. has acquired Vyrsa Technologies, a private medical technology company specializing in minimally invasive treatment for chronic sacroiliac joint pain. Nevro paid $40 million at closing and may pay up to an additional $35 million in cash or stock, contingent on achieving certain milestones.
November 30, 2023 | 10:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Nevro Corp. has completed the acquisition of Vyrsa Technologies, with an initial payment of $40 million and potential additional payments of up to $35 million based on milestones.
The acquisition of Vyrsa Technologies could potentially enhance Nevro's product offerings and market position in the treatment of chronic pain, which may be viewed positively by investors. The initial payment is substantial, and the additional milestone payments indicate a strong commitment to the success of the acquired technology. This could lead to increased investor confidence and a potential short-term uptick in NVRO's stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100